Vimarsana
Biggest News Aggregation in the World

Eric Raabe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Raabe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Raabe Today - Breaking & Trending Today

KAZIA PRESENTS NEW DATA FOR PAXALISIB AND EVT801 AT AACR ANNUAL MEETING - Vimarsana News

KAZIA PRESENTS NEW DATA FOR PAXALISIB AND EVT801 AT AACR ANNUAL MEETING

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the presentation of...

New law gives Pittsburgh region climate funds, more jobs, cleaner air and hope - Vimarsana News

New law gives Pittsburgh region climate funds, more jobs, cleaner air and hope

The Inflation Reduction Act, which was signed into law by President Biden on Wednesday, has given new life to efforts in the Pittsburgh region to limit the worst impacts of climate change.

Source: wesa.fm
Pittsburgh suburbs closer to passing climate plans - Vimarsana News

Pittsburgh suburbs closer to passing climate plans

A new report provides a road map and emissions data for Pittsburgh suburbs that want to reduce their greenhouse gas emissions. Together the 35 communities emit more greenhouse gases than Pittsburgh.

Source: wesa.fm
Kazia Therapeutics Ltd encouraged by "promising data" on its cancer pipeline presented at AACR meeting in New Orleans - Vimarsana News

Kazia Therapeutics Ltd encouraged by "promising data" on its cancer pipeline presented at AACR meeting in New Orleans

Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) is set to have a busy few days at the American Association for Cancer Research (AACR) annual meeting in New...

KAZIA THERAPEUTICS ANNOUNCES PRECLINICAL DATA PRESENTED AT AACR CONFERENCE BY JOHNS HOPKINS UNIVERSITY SHOWING ACTIVITY OF PAXALISIB IN PAEDIATRIC BRAIN TUMOURS - Vimarsana News

KAZIA THERAPEUTICS ANNOUNCES PRECLINICAL DATA PRESENTED AT AACR CONFERENCE BY JOHNS HOPKINS UNIVERSITY SHOWING ACTIVITY OF PAXALISIB IN PAEDIATRIC BRAIN TUMOURS

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce new preclinical data...